Not Signed In -
Stomach Disorders |
Delayed Gastric Emptying /Gastroparesis; Ménétrier's Disease |
Clinical Trial: Early Phase II Trials for Cocaine Medication Development - 1
This study is no longer recruiting patients.
Purpose
The purpose of this study is to develop models for early Phase II testing of potential medications for cocaine dependence: amoxapine, risperidone and other agents.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Cocaine-Related Disorders Substance-Related Disorders | Drug: Risperidone | Phase II |
MedlinePlus related topics: Cocaine Abuse; Drug Abuse; Prescription Drug Abuse
Study Type: Interventional
Study Design: Treatment, Uncontrolled
Official Title: Early Phase II Trials for Cocaine Medication Development
Further Study Details:
Expected Total Enrollment: 25
Study start: June 1994
Eligibility
Ages Eligible for Study: 18 Years - 60 Years, Genders Eligible for Study: Both
Criteria
Please contact site for information.
Location Information
New York
Research Foundation for Mental Hygiene, New York, New York, 10032, United States
Study chairs or principal investigators
Edward Nunes, M.D., Principal Investigator, Research Foundation for Mental Hygiene
More Information
Study ID Numbers: NIDA-09582-1; R01-09582-1
Record last reviewed: December 2002
Last Updated: March 17, 2005
Record first received: September 20, 1999
ClinicalTrials.gov Identifier: NCT00000317
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: December 2002
Last Updated: March 17, 2005
Record first received: September 20, 1999
ClinicalTrials.gov Identifier: NCT00000317
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
